×
Hero Background

Seropositive Rheumatoid Arthritis Drug Companies

ID: MRFR/Pharma/4123-HCR
90 Pages
Rahul Gotadki
October 2025

Seropositive rheumatoid arthritis refers to a form of rheumatoid arthritis where individuals test positive for certain antibodies, such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs). Drug companies play a crucial role in developing and providing medications to manage symptoms and slow the progression of seropositive rheumatoid arthritis.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Seropositive Rheumatoid Arthritis Drug Market Research Report- Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Seropositive Rheumatoid Arthritis Drug Market

Seropositive Rheumatoid Arthritis Drug Market

 


Latest Seropositive Rheumatoid Arthritis Drug Companies Updates:


AbbVie receives FDA approval for Rinvoq® (upadacitinib) for the treatment of active adult psoriatic arthritis, expanding its reach beyond rheumatoid arthritis: This approval strengthens


AbbVie's position in the autoimmune disease treatment landscape.


Pfizer announces positive Phase 3 trial results for Xeljanz® (tofacitinib) in combination with methotrexate for the treatment of active psoriatic arthritis: These results further demonstrate the potential of Xeljanz as an effective treatment option for this condition.


Roche launches Tecentriq® (atezolizumab) in combination with methotrexate for the treatment of adult patients with moderate-to-severe rheumatoid arthritis who have had an


inadequate response to one or more DMARDs: This represents a significant step forward in immunotherapy options for rheumatoid arthritis.


List of Seropositive Rheumatoid Arthritis Drug Key companies in the market:



  • Abbott Laboratories (U.S.)

  • Johnson & Johnson Limited (U.S.)

  • Novartis AG (Switzerland)

  • Pfizer, Inc. (U.S.)

  • Eli Lilly and Company (U.S.)

  • AbbVie Inc. (U.S.)

  • Bristol-Myers Squibb Company (U.S.)

  • F. Hoffmann-La Roche Ltd. (Switzerland)